Aveo Pharmaceuticals, Inc.
Records under this name other than the patents Aveo Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 24 patents it holds.
Back to Aveo Pharmaceuticals, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,943,344 | Hepatocyte growth factor (HGF) binding proteins Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,273,355 | Hepatocyte growth factor (HGF) binding proteins Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 7,649,083 | Hepatocyte growth factor (HGF) binding antibody Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,896,730 | Use of EMT gene signatures in cancer drug discovery, diagnostics, and treatment Lapsed on the fee record Ended Feb 20, 2022 · From the USPTO record | Lapsed on the fee record | Ended Feb 20, 2022 | From the USPTO record |
| US 7,544,476 | Identifying cancers sensitive to treatment with inhibitors of notch signaling Lapsed on the fee record Ended Jun 9, 2021 · From the USPTO record | Lapsed on the fee record | Ended Jun 9, 2021 | From the USPTO record |
| US 8,373,017 | Reconstituted human breast tumor model Lapsed on the fee record Ended Feb 12, 2021 · From the USPTO record | Lapsed on the fee record | Ended Feb 12, 2021 | From the USPTO record |
| US 9,345,788 | Reconstituted human breast tumor model Lapsed on the fee record Ended May 24, 2020 · From the USPTO record | Lapsed on the fee record | Ended May 24, 2020 | From the USPTO record |
| US 8,829,164 | Anti-ron antibodies Lapsed on the fee record Ended Sep 9, 2018 · From the USPTO record | Lapsed on the fee record | Ended Sep 9, 2018 | From the USPTO record |
| US 7,736,861 | Tivozanib Response Prediction Lapsed on the fee record Ended Jun 15, 2018 · High confidence | Lapsed on the fee record | Ended Jun 15, 2018 | High confidence |
| US 8,603,478 | Anti-RON antibodies Lapsed on the fee record Ended Dec 10, 2017 · From the USPTO record | Lapsed on the fee record | Ended Dec 10, 2017 | From the USPTO record |